Marks Group Wealth Management, Inc Amgen Inc Transaction History

Marks Group Wealth Management, Inc

  • $967 Million
  • Q4 2024

A detailed history of Marks Group Wealth Management, Inc transactions in Amgen Inc stock. As of the latest transaction made, Marks Group Wealth Management, Inc holds 5,939 shares of AMGN stock, worth $1.73 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
5,939
Previous 6,270 5.28%
Holding current value
$1.73 Million
Previous $2.02 Million 23.42%
% of portfolio
0.16%
Previous 0.2%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
SELL
$258.78 - $328.31 $85,656 - $108,670
-331 Reduced 5.28%
5,939 $1.55 Million
Q3 2024

Oct 30, 2024
SELL
$309.38 - $337.38 $11,137 - $12,145
-36 Reduced 0.57%
6,270 $2.02 Million
Q2 2024

Aug 14, 2024
SELL
$262.75 - $319.31 $326,335 - $396,583
-1,242 Reduced 16.45%
6,306 $1.97 Million
Q1 2024

Apr 29, 2024
SELL
$268.87 - $324.56 $197,081 - $237,902
-733 Reduced 8.85%
7,548 $2.15 Million
Q4 2023

Feb 01, 2024
SELL
$255.7 - $288.46 $250,841 - $282,979
-981 Reduced 10.59%
8,281 $2.39 Million
Q3 2023

Oct 30, 2023
SELL
$218.65 - $271.46 $150,212 - $186,493
-687 Reduced 6.91%
9,262 $2.49 Million
Q2 2023

Jul 19, 2023
BUY
$214.27 - $253.37 $20,569 - $24,323
96 Added 0.97%
9,949 $2.21 Million
Q1 2023

May 03, 2023
BUY
$225.79 - $275.2 $327,847 - $399,590
1,452 Added 17.28%
9,853 $2.38 Million
Q4 2022

Feb 06, 2023
BUY
$229.03 - $291.01 $152,304 - $193,521
665 Added 8.6%
8,401 $2.21 Million
Q3 2022

Nov 10, 2022
BUY
$224.46 - $253.15 $189,668 - $213,911
845 Added 12.26%
7,736 $1.74 Million
Q2 2022

Aug 09, 2022
BUY
$230.71 - $256.74 $259,548 - $288,832
1,125 Added 19.51%
6,891 $1.68 Million
Q1 2022

May 10, 2022
BUY
$219.27 - $242.57 $367,277 - $406,304
1,675 Added 40.94%
5,766 $1.39 Million
Q4 2021

Feb 14, 2022
BUY
$198.88 - $227.6 $194,504 - $222,592
978 Added 31.42%
4,091 $677,000
Q3 2021

Nov 15, 2021
SELL
$212.27 - $248.7 $68,775 - $80,578
-324 Reduced 9.43%
3,113 $667,000
Q2 2021

Aug 10, 2021
BUY
$233.58 - $259.14 $31,066 - $34,465
133 Added 4.03%
3,437 $840,000
Q1 2021

May 17, 2021
BUY
$221.91 - $258.6 $42,384 - $49,392
191 Added 6.14%
3,304 $813,000
Q4 2020

Feb 08, 2021
BUY
$216.38 - $257.67 $19,690 - $23,447
91 Added 3.01%
3,113 $716,000
Q3 2020

Nov 10, 2020
BUY
$234.65 - $260.95 $5,631 - $6,262
24 Added 0.8%
3,022 $768,000
Q2 2020

Aug 10, 2020
BUY
$197.81 - $242.74 $95,146 - $116,757
481 Added 19.11%
2,998 $712,000
Q1 2020

Apr 23, 2020
SELL
$182.24 - $241.7 $85,652 - $113,599
-470 Reduced 15.73%
2,517 $509,000
Q4 2019

Feb 12, 2020
BUY
$189.21 - $243.2 $565,170 - $726,438
2,987 New
2,987 $720,000

Others Institutions Holding AMGN

# of Institutions
3,144
Shares Held
415M
Call Options Held
8.2M
Put Options Held
6.65M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $156B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Marks Group Wealth Management, Inc Portfolio

Follow Marks Group Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marks Group Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Marks Group Wealth Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email